Publications:

Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal

Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL

Publication Date: 2019-04

Variant appearance in text: rs28969421

PubMed Link: 30214008

Variant Present in the following documents:

• NIHMS1503453-supplement-3.xlsx, sheet 1

View BVdb publication page

Variants in the CYP2B6 3'UTR Alter In Vitro and In Vivo CYP2B6 Activity: Potential Role of MicroRNAs.

Clinical Pharmacology And Therapeutics

Burgess, Kimberly S KS; Ipe, Joseph J; Swart, Marelize M; Metzger, Ingrid F IF; Lu, Jessica J; Gufford, Brandon T BT; Thong, Nancy N; Desta, Zeruesenay Z; Gaedigk, Roger R; Pearce, Robin E RE; Gaedigk, Andrea A; Liu, Yunlong Y; Skaar, Todd C TC

Publication Date: 2018-07

Variant appearance in text: rs28969421

PubMed Link: 28960269

Variant Present in the following documents:

• Main text

View BVdb publication page

Genetic variation in the 3'-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance.

Frontiers In Genetics

Swart, Marelize M; Dandara, Collet C

Publication Date: 2014

Variant appearance in text: rs28969421

PubMed Link: 24926315

Variant Present in the following documents:

• Main text
• fgene-05-00167.pdf

View BVdb publication page